Literature DB >> 16583189

New thoughts on the pathobiology of regimen-related mucosal injury.

Lowell Anthony1, Joanne Bowen, Adam Garden, Ian Hewson, Stephen Sonis.   

Abstract

BACKGROUND: Our understanding of the biological basis for mucosal barrier injury (mucositis) induced by cancer therapy with radiation or drugs continues to evolve. A patient's mucosal response to cancer therapy appears to be controlled by both global (i.e. gender, underlying systemic disease, race) and tissue specific (i.e. epithelial type, intrinsic endocrine system, local microbial environment, function) factors.
CONCLUSION: Interactions of these elements, coupled with underlying genetic influences, most likely govern the risk, course and severity of regimen-related mucosal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583189     DOI: 10.1007/s00520-006-0058-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  19 in total

1.  Circadian variation of topoisomerase II-alpha in human rectal crypt epithelium: implications for reduction of toxicity of chemotherapy.

Authors:  Frederic Clayton; Kathryn A Tessnow; John C Fang; Joseph A Holden; John G Moore
Journal:  Mod Pathol       Date:  2002-11       Impact factor: 7.842

Review 2.  Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions.

Authors:  Andrei Barasch; Douglas E Peterson
Journal:  Oral Oncol       Date:  2003-02       Impact factor: 5.337

Review 3.  War and peace at mucosal surfaces.

Authors:  Philippe J Sansonetti
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

Review 4.  Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease.

Authors:  Brian L Kelsall; Francisco Leon
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

5.  Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes.

Authors:  Ann S J Yeoh; Joanne M Bowen; Rachel J Gibson; Dorothy M K Keefe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-15       Impact factor: 7.038

6.  Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans.

Authors:  Joanne M Bowen; Rachel J Gibson; Dorothy M Keefe; Adrian G Cummins
Journal:  Pathology       Date:  2005-02       Impact factor: 5.306

7.  Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.

Authors:  Kari Chansky; Jacqueline Benedetti; John S Macdonald
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

8.  Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

Authors:  A David McCollum; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

9.  Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy.

Authors:  K A Grötz; S Genitsariotis; D Vehling; B Al-Nawas
Journal:  Support Care Cancer       Date:  2003-08-09       Impact factor: 3.603

Review 10.  Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Authors:  N M Blijlevens; J P Donnelly; B E De Pauw
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

View more
  13 in total

Review 1.  Mucositis guidelines: what have they achieved, and where to from here?

Authors:  Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-03-30       Impact factor: 3.603

2.  The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles.

Authors:  Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2012-11-17       Impact factor: 3.603

Review 3.  Systematic review of basic oral care for the management of oral mucositis in cancer patients.

Authors:  Deborah B McGuire; Janet S Fulton; Jumin Park; Carlton G Brown; M Elvira P Correa; June Eilers; Sharon Elad; Faith Gibson; Loree K Oberle-Edwards; Joanne Bowen; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

Review 4.  The pathogenesis of mucositis: updated perspectives and emerging targets.

Authors:  J Bowen; N Al-Dasooqi; P Bossi; H Wardill; Y Van Sebille; A Al-Azri; E Bateman; M E Correa; J Raber-Durlacher; A Kandwal; B Mayo; R G Nair; A Stringer; K Ten Bohmer; D Thorpe; R V Lalla; S Sonis; K Cheng; S Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

Review 5.  Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls.

Authors:  Dorothy M Keefe; Douglas E Peterson; Mark M Schubert
Journal:  Support Care Cancer       Date:  2006-04-07       Impact factor: 3.603

Review 6.  Management of oral mucositis in patients who have cancer.

Authors:  Rajesh V Lalla; Stephen T Sonis; Douglas E Peterson
Journal:  Dent Clin North Am       Date:  2008-01

Review 7.  Emerging evidence on the pathobiology of mucositis.

Authors:  Noor Al-Dasooqi; Stephen T Sonis; Joanne M Bowen; Emma Bateman; Nicole Blijlevens; Rachel J Gibson; Richard M Logan; Raj G Nair; Andrea M Stringer; Roger Yazbeck; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-04-21       Impact factor: 3.603

8.  Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report.

Authors:  Arsinoi Xanthinaki; Ourania Nicolatou-Galitis; Pavlina Athanassiadou; Maria Gonidi; Vassilis Kouloulias; Anastasia Sotiropoulou-Lontou; George Pissakas; Konstantinos Kyprianou; John Kouvaris; Efstratios Patsouris
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

Review 9.  Emerging evidence on the pathobiology of mucositis.

Authors:  Noor Al-Dasooqi; Stephen T Sonis; Joanne M Bowen; Emma Bateman; Nicole Blijlevens; Rachel J Gibson; Richard M Logan; Raj G Nair; Andrea M Stringer; Roger Yazbeck; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-11       Impact factor: 3.603

10.  New pathways for alimentary mucositis.

Authors:  Joanne M Bowen; Dorothy M K Keefe
Journal:  J Oncol       Date:  2008-09-23       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.